Covant Therapeutics

Private

Boston, MassachusettsHealthcare & Life Scienceshttps://www.covanttx.com/

Last Round

Strategic

Mar 28, 2023

Total Funding Raised

$10M

Company Overview

Covant Therapeutics is a biotechnology company that develops novel oral covalent small molecules and long-acting injectable therapeutics for inflammation and immunology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

covalent drug discoverychemoproteomicssmall molecule therapeuticsai drug discoverydrug discovery platformin silico drug discoveryautoimmune disease treatmentoncology therapeuticsFcRn inhibitorsADAR1 inhibitorsstructural proteomicsbiotech licensinghard-to-drug targetscomputational biologybiotech partnership

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Covant Therapeutics Comparables

Compare Covant Therapeutics with similar companies based on industry and business-model similarity.

Covant Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Nexo Therapeutics	90%
Hyku Biosciences	89%
Matchpoint Therapeutics	82%

View all Comparables

Covant Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Strategic	Mar 28, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Matt Maisak

Co-Founder & CEO

Founding Team

Covant Therapeutics Investors

Notable investors and investment history

Covant Therapeutics investors
Investor	Rounds
Boehringer Ingelheim	Strategic

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Dec 16, 2024
Monthly visitors grew 213% MoM.

View all signals

Covant Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Covant Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Covant Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts

Employee Range15

Year Founded2022

Last FundingMar 28, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.